These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 38534785)

  • 1. Cellular Organelle-Related Transcriptomic Profile Abnormalities in Neuronopathic Types of Mucopolysaccharidosis: A Comparison with Other Neurodegenerative Diseases.
    Wiśniewska K; Gaffke L; Żabińska M; Węgrzyn G; Pierzynowska K
    Curr Issues Mol Biol; 2024 Mar; 46(3):2678-2700. PubMed ID: 38534785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene Expression-Related Changes in Morphologies of Organelles and Cellular Component Organization in Mucopolysaccharidoses.
    Gaffke L; Pierzynowska K; Rintz E; Cyske Z; Giecewicz I; Węgrzyn G
    Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33803318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dysregulation of genes coding for proteins involved in metabolic processes in mucopolysaccharidoses, evidenced by a transcriptomic approach.
    Pierzynowska K; Deresz P; Węgrzyn G; Gaffke L
    Metab Brain Dis; 2023 Aug; 38(6):2133-2144. PubMed ID: 37195412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of genes involved in apoptosis is dysregulated in mucopolysaccharidoses as revealed by pilot transcriptomic analyses.
    Brokowska J; Pierzynowska K; Gaffke L; Rintz E; Węgrzyn G
    Cell Biol Int; 2021 Mar; 45(3):549-557. PubMed ID: 32125037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Underestimated Aspect of Mucopolysaccharidosis Pathogenesis: Global Changes in Cellular Processes Revealed by Transcriptomic Studies.
    Gaffke L; Pierzynowska K; Podlacha M; Hoinkis D; Rintz E; Brokowska J; Cyske Z; Wegrzyn G
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32054071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic potential of lithium chloride and valproic acid against neuronopathic types of mucopolysaccharidoses through induction of the autophagy process.
    Gaffke L; Firyn N; Rintz E; Pierzynowska K; Piotrowska E; Mazur-Marzec H; Węgrzyn G
    Arch Biochem Biophys; 2023 Oct; 747():109754. PubMed ID: 37708928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Why are behaviors of children suffering from various neuronopathic types of mucopolysaccharidoses different?
    Węgrzyn G; Jakóbkiewicz-Banecka J; Narajczyk M; Wiśniewski A; Piotrowska E; Gabig-Cimińska M; Kloska A; Słomińska-Wojewódzka M; Korzon-Burakowska A; Węgrzyn A
    Med Hypotheses; 2010 Dec; 75(6):605-9. PubMed ID: 20732748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in expressions of genes involved in the regulation of cellular processes in mucopolysaccharidoses as assessed by fibroblast culture-based transcriptomic analyses.
    Gaffke L; Pierzynowska K; Krzelowska K; Piotrowska E; Węgrzyn G
    Metab Brain Dis; 2020 Dec; 35(8):1353-1360. PubMed ID: 32886284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptomic Changes Related to Cellular Processes with Particular Emphasis on Cell Activation in Lysosomal Storage Diseases from the Group of Mucopolysaccharidoses.
    Rintz E; Gaffke L; Podlacha M; Brokowska J; Cyske Z; Węgrzyn G; Pierzynowska K
    Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32366041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased Levels of Chaperones in Mucopolysaccharidoses and Their Elevation as a Putative Auxiliary Therapeutic Approach.
    Żabińska M; Gaffke L; Bielańska P; Podlacha M; Rintz E; Cyske Z; Węgrzyn G; Pierzynowska K
    Pharmaceutics; 2023 Feb; 15(2):. PubMed ID: 36840025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in gene expression patterns, revealed by RNA-seq analysis, between various Sanfilippo and Morquio disease subtypes.
    Wiśniewska K; Gaffke L; Krzelowska K; Węgrzyn G; Pierzynowska K
    Gene; 2022 Feb; 812():146090. PubMed ID: 34896230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic Base of Behavioral Disorders in Mucopolysaccharidoses: Transcriptomic Studies.
    Pierzynowska K; Gaffke L; Podlacha M; Węgrzyn G
    Int J Mol Sci; 2020 Feb; 21(3):. PubMed ID: 32050523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Community consensus for Heparan sulfate as a biomarker to support accelerated approval in Neuronopathic Mucopolysaccharidoses.
    Muenzer J; Ho C; Lau H; Dant M; Fuller M; Boulos N; Dickson P; Ellinwood NM; Jones SA; Zanelli E; O'Neill C
    Mol Genet Metab; 2024 Aug; 142(4):108535. PubMed ID: 39018614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impairment of glycosaminoglycan synthesis in mucopolysaccharidosis type IIIA cells by using siRNA: a potential therapeutic approach for Sanfilippo disease.
    Dziedzic D; Wegrzyn G; Jakóbkiewicz-Banecka J
    Eur J Hum Genet; 2010 Feb; 18(2):200-5. PubMed ID: 19690584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurobehavioral phenotypes of neuronopathic mucopolysaccharidoses.
    Barone R; Pellico A; Pittalà A; Gasperini S
    Ital J Pediatr; 2018 Nov; 44(Suppl 2):121. PubMed ID: 30442188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired neural differentiation of MPS IIIA patient induced pluripotent stem cell-derived neural progenitor cells.
    Lehmann RJ; Jolly LA; Johnson BV; Lord MS; Kim HN; Saville JT; Fuller M; Byers S; Derrick-Roberts ALK
    Mol Genet Metab Rep; 2021 Dec; 29():100811. PubMed ID: 34712574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of Fluid Biomarkers Reveals Lysosome Dysfunction and Neurodegeneration in Neuronopathic MPS II Patients.
    Bhalla A; Ravi R; Fang M; Arguello A; Davis SS; Chiu CL; Blumenfeld JR; Nguyen HN; Earr TK; Wang J; Astarita G; Zhu Y; Fiore D; Scearce-Levie K; Diaz D; Cahan H; Troyer MD; Harris JM; Escolar ML
    Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32707880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell cycle disturbances in mucopolysaccharidoses: Transcriptomic and experimental studies on cellular models.
    Brokowska J; Gaffke L; Pierzynowska K; Cyske Z; Węgrzyn G
    Exp Biol Med (Maywood); 2022 Sep; 247(18):1639-1649. PubMed ID: 36000158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired ion homeostasis as a possible associate factor in mucopolysaccharidosis pathogenesis: transcriptomic, cellular and animal studies.
    Gaffke L; Szczudło Z; Podlacha M; Cyske Z; Rintz E; Mantej J; Krzelowska K; Węgrzyn G; Pierzynowska K
    Metab Brain Dis; 2022 Feb; 37(2):299-310. PubMed ID: 34928474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcriptomic analyses suggest that mucopolysaccharidosis patients may be less susceptible to COVID-19.
    Pierzynowska K; Gaffke L; Węgrzyn G
    FEBS Lett; 2020 Oct; 594(20):3363-3370. PubMed ID: 32880920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.